Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-17

Clinical Trial Update: Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol [Phase 2]

View source ↗

Summary

Phase 2 integrated clinical protocol for Mission Connect addressing mild traumatic brain injury was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Baylor College of Medicine | Conditions: Traumatic Brain Injury, Post-traumatic Stress Disorder | Phase 2 | Status: TERMINATED | Results posted: 2016-11-17